Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

International Workshop: Infant Formula Adulteration With Melamine Underscores Need For Better Detection Methods
Following the recent adulteration of infant formula and other milk products with the industrial chemical melamine, the U. S. Pharmacopeial (USP) Convention is holding an international workshop this week to explore better ways to detect deliberately falsified protein content in food ingredients. The presence of false protein can lead to illness and death, as with thousands of Chinese children in the tragic melamine adulteration of infant formula this year and with pets in the United States in 2007. Vulnerabilities in global supply chains for food and drug ingredients allow such adulteration to affect people worldwide, which is what happened in similar instances where toxic diethylene glycol was substituted for the sweetener glycerin in toothpaste and cough syrup. USP is a scientific nonprofit organization that sets official standards for the identity, quality, purity, and strength of prescription and over-the-counter drugs. USP also sets widely recognized standards for the quality and purity of food ingredients and dietary supplements.

Providers And Medicare Battle: Who Owns Home Oxygen Equipment?
A new Medicare rule limiting payments for oxygen providers is prompting an aggressive lobbying campaign by the industry, and unintended consequences for patients, the Cleveland Plain Dealer reports:
News of the day
Study Finds People Residing In Poor Communities Not Benefiting From Recent Drop In Colorectal Cancer
A new study suggests that a drop in colorectal cancer incidence seen nationwide has not occurred among people living in poorer communities, and suggests that barriers to health care may be to blame. The study appears online in the journal Cancer Causes and Control.
Nutrition

MUHC Researcher Awarded $500,000 To Study Pathogenesis Of Infectious Disease

The Burroughs Wellcome Fund (BWF) has announced the recipients of the 2009 Investigators in the Pathogenesis of Infectious Disease Award. MUHC researcher Dr. Maya Saleh was one of six recipients granted $500,000 over a 6-year period for her research proposal, "Regulation and molecular mechanisms of NLR-mediated innate immunity." "We are studying how the body fights infections," says Dr. Saleh, who was the only researcher in Canada to receive the award. "Our focus is the innate immune system, which is our body"s first line of defense. We are performing experiments at the level of the whole genome to find most of the genes needed for this defense. By using genetics and genomics we are hoping to see the whole picture." The BWF program is intended to shed light on the overarching issues of how human hosts handle infectious challenge. The awards are designed to give recipients the freedom and flexibility to pursue new avenues of inquiry and higher-risk research projects that hold potential for advancing significantly the biochemical, pharmacological, immunological, and molecular biological understanding of how infectious agents and the human body interact. The selection process for this award is based on the proposal and on the achievement of the scientist, in the US or Canada, as a new independent investigator. It also takes into consideration the research environment and institutional support. By identifying various molecules involved in our body"s defense, Dr. Saleh and her team hope to widen the therapeutic targets in humans. "We could start tailoring experiments where we design, then use drugs to modulate the action of the molecules we identify," says Dr. Saleh. "We currently have one family of such molecules that we are investigating. These are enzymes that are needed for the production of defence molecules (cytokines) called The Inflammatory Caspases." "Infectious diseases remain a concern to global health," says BWF President Dr. John Burris. "We are proud to support the work of creative investigators who study the crucial interaction between the host and the microbe." Notes: Dr. Maya Saleh Dr. Maya Saleh is a researcher with the Critical Care Division and the Centre for the Study of Host Resistance at the Research Institute of the McGill University Health Centre (MUHC) as well as an assistant professor with McGill University"s Faculty of Medicine. The Burroughs Wellcome Fund The Investigators in the Pathogenesis of Infectious Disease award provides $500,000 during a five-year period to encourage multidisciplinary approaches to investigating pathogenesis. BWF launched the program in 2002 and has made 78 awards for an investment of more than $33 million in the careers of assistant professor-level researchers who are working on understanding the interactions between the human host and the infectious agent - bacterial, viral, fungal, or parasitic. This year due to the economic environment the award will be spread out over 6 years. The Research Institute of the McGill University Health Centre (RI MUHC) is a world-renowned biomedical and healthcare hospital research centre. Located in Montreal, Quebec, the Institute is the research arm of the MUHC, the university health centre affiliated with the Faculty of Medicine at McGill University. The Institute supports over 600 researchers, nearly 1,200 graduate and post-doctoral students; it also operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge. The Research Institute of the MUHC is supported in part by the Fonds de la recherche en santçİ du Quçİbec. The McGill University Health Centre The McGill University Health Centre (MUHC) is a comprehensive academic health institution with an international reputation for excellence in clinical programs, research and teaching. Its partner hospitals are the Montreal Children"s Hospital, the Montreal General Hospital, the Royal Victoria Hospital, the Montreal Neurological Hospital, the Montreal Chest Institute and the Lachine Hospital. The goal of the MUHC is to provide patient care based on the most advanced knowledge in the health care field and to contribute to the development of new knowledge. Isabelle Kling McGill University Health Centre


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

İ Copyright 2009